HEALTH

Mobile app helps patients, cos. increase adherence

BY Michael Johnsen

Diabetics are most adherent around meal times, especially during breakfast and toward the beginning of the week, according to a review of Medisafe’s more than 160,000 diabetes patients who utilize its adherence tool in an effort to better manage the condition.

(To view the full Diabetes Report, click here.)

“It makes sense — you wake up and have breakfast and take your medication — it’s routine,” Jon Michaeli, EVP marketing and business development for Medisafe, told Drug Store News.

Another interesting finding: Patients managing their diabetes using insulin are slightly more adherent (76%) than patients who use only oral medications to manage their diabetes (74%). “[This shows] there are different types of patients, perhaps, [who] are more dependent on their diabetes medications and [subsequently] have higher levels of adherence,” Michaeli said.

According to the Centers for Disease Control and Prevention, approximately 2.9 million patients manage diabetes using insulin only, 3.1 million patients manage their diabetes using a combination of insulin and oral medications and 11.9 million patients manage their diabetes using oral medications alone.

All told, approximately 3.2 million patients utilize Medisafe’s mobile app adherence tools to help better manage the health condition, and earlier this year Medisafe opened that patient population to pharmaceutical partners through its Medisafe for Pharma offering. Following successful pilots, Medisafe has bundled a number of services into a software license that helps pharmaceutical companies increase adherence to their medications while gaining actionable, insights generated by complex, self-learning algorithms analyzing billions of user engagement data points Medisafe has collected to date.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

Apps help Type 2 patients self-manage disease

BY Michael Johnsen

Cardiff University in October found that smartphone apps could offer patients with Type 2 diabetes a highly effective method of self-managing their condition.

(To view the full Diabetes Report, click here.)

“As we enter an era where portable technology increasingly is used to improve our lifestyles, as can already be seen with physical activity technology, apps can offer a large percentage of the world’s population a low-cost and dynamic solution to Type 2 diabetes management,” noted Ben Carter from Cardiff University’s School of Medicine. “By the end of the decade, it is predicted that global usage of mobile phones will exceed 5 billion, so apps, used in combination with other self-management strategies, could form the basis of diabetes education and self-management.”

A systematic review of 14 previous studies involving 1,360 patients found that all had reported a reduction in average blood-glucose levels in patients who used an app, compared with those who did not, with an approximate reduction in HbA1c of about 0.5%. The analysis also found that younger patients were more likely to report a benefit.

Diabetes management includes monitoring and managing blood-glucose levels. Current diabetes apps allow patients to enter data and provide feedback on improved management.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

Omnis Health launches new gestational diabetes care kit

BY Michael Johnsen

NASHVILLE — Earlier this year, Omnis Health created a dedicated diabetes-management solution for some 375,000 women diagnosed with gestational diabetes who are extremely passionate, both about managing their condition and the health of their newborns. It’s certainly a niche category, but the retailer who provides a direct solution to gestational diabetes may capture that family’s entire health spend moving forward.

(To view the full Diabetes Report, click here.)

“It’s a segment that, unfortunately, gets rolled into the general population of diabetes as a whole,” Cathy Pereira, Omnis Health EVP global sales and marketing, told Drug Store News earlier this year. “When we looked at gestational diabetes, no one is paying attention to this segment,” she said. “[Approximately] 9.3% of pregnant women develop gestational diabetes, [and] these women are looking for education and for someone to walk and guide them through the process of, ‘What does this mean now?’”

To help facilitate the connective tissue between retailer and that pregnant mom, Omnis Health couples a nine-week care kit with a communication and marketing vehicle. “Embrace Better Care creates an effective way to tether customers to the pharmacies where they purchased their Embrace brand products, while building loyalty to that pharmacy,” Pereira said.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES